ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
J01DD15 | G | Cefdinir - 300mg | 8340 | 186808/14 | SEFARIN | 300mg | 10 | Capsule | Oral | Picomed SARL | Pharma International Co Ltd | Jordan | 1,494,353 L.L | 23.08 | B | Pharma International Co Ltd | Jordan | 2/5/2024 | 0 |
ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
J01DD15 | B | Cefdinir - 300mg | 8839 | 87216/1 | OMNICEF | 300mg | 10 | Capsule | Oral | Droguerie de l'Union | Jazeera Pharmaceutical Industries under licence of Astellas Pharma Inc Japan | Saudi Arabia | 2,238,842 L.L | 23.08 | B | Hikma Pharmaceuticals | Jordan | 2/5/2024 | 0 |
J01DD15 | B | Cefdinir - 300mg | 3851 | 194003/05 | OMNICEF 300 | 300mg | 10 | Capsule | Oral | Droguerie de l'Union | Hikma Pharmaceuticals under license of Astellas Pharma Inc Japan | Jordan | 2,238,842 L.L | 23.08 | B | 2/5/2024 | 0 | ||
J01DD15 | G | Cefdinir - 300mg | 11404 | 144321/1 | MINOCET | 300mg | 10 | Capsule | Oral | Mersaco | Tabuk Pharmaceutical Manufacturing Company | Saudi Arabia | 1,407,003 L.L | 23.08 | A2 | Tabuk Pharmaceutical Manufacturing Company | Saudi Arabia | 2/5/2024 | 0 |